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ABSTRACT
Pneumonia caused by the opportunistic organism Pneumocystis jirovecii is a clinically important infection
affecting AIDS and other immunocompromised patients. The present study aimed to compare and
characterise the frequency pattern of DNA sequences from the P. jirovecii mitochondrial large-subunit
rRNA (mtLSU rRNA) gene, the dihydropteroate synthase (DHPS) gene and the internal transcribed spacer
(ITS) regions of the nuclear rRNA operon in specimens from Lisbon (Portugal) and Seville (Spain). Total
DNA was extracted and used for speciﬁc molecular sequence analysis of the three loci. In both popula-
tions, mtLSU rRNA gene analysis revealed an overall prevalence of genotype 1. In the Portuguese
population, genotype 2 was the second most common, followed by genotype 3. Inversely, in the Spanish
population, genotype 3 was the second most common, followed by genotype 2. The DHPS wild-type
sequence was the genotype observed most frequently in both populations, and the DHPS genotype
frequency pattern was identical to distribution patterns revealed in other European studies. ITS
types showed a signiﬁcant diversity in both populations because of the high sequence variability in
these genomic regions. Themost prevalent ITS type in the Portuguese population was Eg, followed by Cg.
In contrast to other European studies, Bi was the most common ITS type in the Spanish samples, followed
by Eg. A statistically signiﬁcant association between mtLSU rRNA genotype 1 and ITS type Eg was
revealed.
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INTRODUCTION
Pneumocystis jirovecii (formerly Pneumocystis cari-
nii f. sp. hominis) pneumonia (PcP) [1,2] is a
common and serious disease in individuals
infected with human immunodeﬁciency virus
(HIV) [3], causing signiﬁcant morbidity and
mortality in the era of highly active anti-retroviral
therapy (HAART) [4,5]. P. jirovecii has also been
isolated from immunocompetent individuals and
patients with moderate degrees of immunodeﬁ-
ciency [6–8]. In addition, patients with lung tissue
damage caused by different clinical conditions
are at increased risk of P. jirovecii colonisation
[6–11].
Therapeutic failure may occur during treatment
or prophylaxis of PcP, and several studies have
suggested that this failure may be correlated with
polymorphisms in speciﬁc genetic loci [12–18].
Recent advances in understanding the molecular
biology of P. jirovecii have raised important ques-
tions concerning the spread of genotypes with
increased pathogenicity and drug resistance
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among the population [19–22]. As this organism
cannot be cultured reliably, it is not possible to
describe differences among isolates using con-
ventional techniques, but molecular typing has
been used successfully for this purpose [2,3].
Several polymorphic loci have been studied in
order to clarify the epidemiological proﬁle of
P. jirovecii, with particular respect to its virulence,
drug resistance and modes of transmission. The
mitochondrial large-subunit rRNA (mtLSU
rRNA), the dihydropteroate synthase (DHPS)
gene and the internal transcribed spacer regions
1 and 2 (ITS1 and ITS2) of the nuclear rRNA
operon are among these loci [12–17,19–28].
The mtLSU rRNA gene is involved in basic
metabolic functions and is considered to be a
highly informative locus [23]. This is also the
locus used most widely for PCR-based detection
of P. jirovecii, as it is present in a large number of
copies. To date, seven different mtLSU rRNA
sequences have been identiﬁed for P. jirovecii,
meaning that these sequences are useful for
investigating intra-speciﬁc differences among
populations [19,20,26].
The DHPS locus has also been studied exten-
sively in recent years because of the occurrence of
mutations that may be a consequence of exposure
to sulphonamides, and that are related to the
emergence of sulphonamide-resistant strains of
P. jirovecii. A potential association of point muta-
tions at codons 55 and 57 with trimethoprim–
sulphamethoxazole resistance has already been
reported [12–15]. These variations suggest that
widespread use of trimethoprim–sulphamethox-
azole may be exerting a selective pressure on
P. jirovecii genotypes circulating among humans
[10,13,15].
ITS1 and ITS2 show the highest level of
sequence variation in P. jirovecii and are consid-
ered to be the most discriminatory DNA regions
for genotyping studies. According to the nomen-
clature of Lee et al. [27], 16 different DNA ITS1
sequences and 15 different ITS2 sequences have
been described, with a total of 60 different
combined types being reported from among a
theoretical total of 240 [24,25,27].
The aim of the present study was to characte-
rise and compare P. jirovecii contained in speci-
mens from HIV-positive and HIV-negative
Portuguese and Spanish patients on the basis of
their mtLSU rRNA genes, DHPS genes and ITS
regions of the nuclear rRNA operon.
MATERIALS AND METHODS
Subjects
In total, 108 samples tested previously and found to be
positive for P. jirovecii between 2001 and 2004 were included
in the study. Fifty-ﬁve pulmonary specimens (11 induced
sputa and 44 bronchoalveolar lavage ﬂuids) were collected
from 48 HIV-positive adult patients and four immunodeﬁ-
cient HIV-negative children (two neonates and two children
aged 4 years with cancer) at several hospitals in Lisbon,
Portugal. Two specimens were collected during the same
episode of PcP from three of the 48 adult patients. Fifty-
three pulmonary specimens (bronchoalveolar lavage ﬂuids)
from 19 HIV-positive adult patients and 34 HIV-negative
adult patients with pulmonary disorders were also collected
at the University Hospital of Seville, Spain. Informed
consent of patients or their guardians was obtained in all
cases and the study was approved by the ethical committees
of the respective institutions.
Detection of P. jirovecii
Genomic DNA from the Portuguese samples was extracted by
a Mini-BeadBeater ⁄guanidinium thiocyanate-silica method
[13], while the Spanish samples were digested at 56C with
proteinase K (Roche, Mannheim, Germany) followed by DNA
extraction using a Qiamp kit (Qiagen, Hilden, Germany). For
both groups of samples, molecular detection of P. jirovecii was
performed by ampliﬁcation of the mtLSU rRNA gene using
nested PCR as described previously [10].
Genotypic characterisation of P. jirovecii
mtLSU rRNA nested PCR products from Portuguese samples
were puriﬁed using a Jetquick PCR puriﬁcation spin kit
(Genomed, St Louis, MO, USA) and were then directly
sequenced from both ends using BigDye terminator (Applied
Biosystems, Foster City, CA, USA) cycling conditions on a
3730xl DNA Analyser (Applied Biosystems). Nucleotide
sequences were aligned and analysed using CLUSTAL W
software v.1.82, available at the European Bioinformatics
Institute website (http://www.ebi.ac.uk/Tools/clustalw2/
index.html) and ChromasPro v.1.22 (Technelysium Pty,
Tewantin, Australia). PCR products from Spanish samples
were puriﬁed using Sephacryl S-400 columns (Amersham
Pharmacia Biotech, Little Chalfont, UK) and were sequenced
on an ABI Prism 310 sequencer (Applied Biosystems) accord-
ing to the manufacturer’s recommendations. The sequenced
DNA fragments were analysed using Sequence Navigator
v.1.0.1 software (Applied Biosystems).
The P. jirovecii DHPS gene was characterised by PCR–
restriction fragment length polymorphism analysis as
described previously [9,13]. A nested-PCR procedure was
used for the Portuguese samples, with external primers Dp800
and Dp15 and internal primers DHPS-NF and DHPS-NR,
which yielded a 186-bp fragment containing the polymorphic
sites [13]. For the Spanish samples, the single-copy DHPS gene
was also ampliﬁed by nested PCR using primers DHPS-3 and
DHPS-4, yielding a 370-bp fragment [9]. For both groups, PCR
products were digested with AccI and HaeIII (Fermentas, Glen
Burnie, MD, USA) to detect polymorphisms at codons 55 and
57 [9,13].
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ITS regions were ampliﬁed by nested PCR for both groups
of samples, with 1724F2 and ITS2R as external primers, and
ITS-FX [27] and ITS-RX (5¢-GTTCAGCGGGTGATCCTGC)
(kindly provided by C.-H. Lee) as internal primers, yielding
an amplicon of 550 bp. Ampliﬁcation products were puriﬁed
using a Jetquick PCR puriﬁcation spin kit. Considering both
groups of samples (55 Portuguese and 53 Spanish samples),
and taking into account previous reports [16,17], 15% of the
samples from each group were randomly selected and their
PCR products were cloned. For this purpose, seven ITS
ampliﬁcation products from Spanish samples and eight prod-
ucts from Portuguese samples were cloned using a pGEM-T
Easy Vectors cloning kit (Promega, Southampton, UK). Four to
six recombinant plasmids of each cloned PCR product were
puriﬁed using a QIAprep Spin Miniprep kit (Qiagen). Plasmid
DNA was digested with restriction endonuclease EcoR1
(Fermentas), analysed by electrophoresis to verify the exis-
tence of cloned inserts, and then sequenced from both ends
using T7 and SP6 promoters ﬂanking the cloning region.
Nucleotide sequencing of PCR and cloned fragments was
conducted under BigDye terminator cycling conditions on a
3730xl DNA Analyser. Molecular sequences were aligned and
analysed using CLUSTAL W and ChromasPro.
Statistical analysis
A descriptive statistical analysis was performed for qualitative
data. Chi-square tests were used to investigate the association
between qualitative variables at a signiﬁcance level of 0.05.
Statistical analysis was performed using SPSS v.13.0 software
(SPSS Inc., Chicago, IL, USA).
RESULTS
Analysis of mtLSU rRNA locus
The mtLSU rRNA primers produced an ampliﬁ-
cation product from 102 (94%) of the 108 pulmo-
nary specimens containing P. jirovecii, including
53 (100%) samples from Spain and 49 (89%) from
Portugal. The results of mtLSU rRNA sequence
analysis are shown in Table 1. The four polymor-
phisms described previously at nucleotide posi-
tions 85 and 248 [19] were also detected in the
present study. Genotype 1 was most common in
both groups of samples (49% in Portugal and
64% in Spain). Genotype 2 was the second most
frequent genotype among the Portuguese samples
(22%) and the third most frequent among the
Spanish samples (11%). In contrast, genotype 3
was the third most frequent genotype among the
Portuguese samples (18%) and the second most
frequent among the Spanish samples (25%).
Genotype 4 was represented by only a single
Portuguese sample. Mixed infections with more
than one P. jirovecii mtLSU rRNA genotype were
detected in four (8%) Portuguese samples. Two
(4%) yielded genotypes 1 and 2, and two others
yielded genotypes 1 and 3. No mixed infections
were detected among the Spanish samples.
Analysis of the DHPS gene
The DHPS primers yielded an ampliﬁcation
product with 91 (84%) of the 108 pulmonary
specimens containing P. jirovecii, including 36
(68%) samples from Spain and 55 (100%) from
Portugal. The sequence variations observed at
nucleotide positions 165 and 171 are summarised
in Table 2 [19]. The wild-type (Wt) sequence was
the most common sequence in both groups of
samples (93% in Portugal and 78% in Spain).
Mutant genotypes were present in four (8%)
Portuguese samples and in eight (29%) Spanish
samples. Mixed genotype infections were found
for two Portuguese samples (Wt and Mut57;
Wt and Mut55 ⁄ 57) and three Spanish samples
(Wt and Mut55; Wt and Mut57; Wt and
Mut55 ⁄ 57).
Analysis of ITS regions
Of 108 pulmonary specimens containing
P. jirovecii, 68 (63%) were ampliﬁed successfully
using nested PCR. The primers speciﬁc for the ITS
Table 1. Pneumocyctis jirovecii mitochondrial large-subunit
(mtLSU) rRNA locus genotypes detected in samples from
Lisbon (Portugal) and Seville (Spain)
mtLSU rRNA
genotypea
Nucleotide
position ⁄
identity
Number (%) of isolates
Portugal Spain Total
1 85C; 248C 24 (49) 34 (64) 58 (57)
2 85A; 248C 11 (22) 6 (11) 17 (17)
3 85T; 248C 9 (18) 13 (25) 22 (22)
4 85C; 248T 1 (2) 0 1 (1)
Mixtureb 4 (8) 0 4 (4)
amtLSU rRNA genotypes are identiﬁed on the basis of polymorphism at nucleotide
positions 85 and 248.
bSamples containing mixed genotypes.
Table 2. Pneumocycstis jirovecii genotypes detected at the
dihydropteroate synthase (DHPS) locus in samples from
Lisbon (Portugal) and Seville (Spain)
DHPS
genotypea
Nucleotide (amino-acid)
position ⁄ identity
Number (%) of isolates
Portugal Spain Total
Wt 165 (55) ⁄A (Thr); 171 (57) ⁄C (Pro) 51 (93) 28 (78) 79 (87)
Mut55 165 (55) ⁄G (Ala); 171 (57) ⁄C (Pro) 0 2 (6) 2 (2)
Mut57 165 (55) ⁄A (Thr); 171 (57) ⁄T (Ser) 0 2 (6) 2 (2)
Mut55 ⁄ 57 165 (55) ⁄G (Ala); 171 (57) ⁄T (Ser) 2 (4) 1 (3) 3 (3)
Mixtureb 2 (4) 3 (8) 5 (6)
aDHPS genotypes are distinguished on the basis of point mutations at codon 55
(Mut55), codon 57 (Mut57), or both (Mut55 ⁄ 57). Wt corresponds to the wild-type
sequence.
bSamples containing mixed genotypes.
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regions yielded ampliﬁcation products from 55
(100%) samples from Portugal and 13 (25%) from
Spain. The results of sequence analysis of the
P. jirovecii ITS regions are summarised in Table 3.
According to the ITS nomenclature of Lee et al.
[27], 12 ITS1 and ten ITS2 sequences were
detected among the 68 samples studied, resulting
in the identiﬁcation of 22 ITS types [27,28].
However, a single ITS type was detected in 52
(95%) of the 68 Portuguese samples, while mixed
infections were found in the remaining three (5%)
samples. The most prevalent ITS types were Eg
(16 samples, 29%), Cg (seven samples, 13%), Gg
(ﬁve samples, 9%), and Cn and Bi (three samples,
5%, each). The ITS types Ai, Ce, Eb, Eh, Ei and Hg
were detected in two (4%) samples each. The
types De, Dg, Jf, Ng, Oe and Ho were detected in
one (2%) sample each. Mixed infections were
identiﬁed for three of the eight samples from
which ampliﬁcation fragments were cloned ran-
domly; two yielded types Eg and Gg, and one
yielded types Eg and Og. Among the 13 samples
from Spain that yielded ampliﬁcation products,
12 (92%) contained a single ITS type and one (8%)
contained two different ITS types. The most
common ITS types were Bi (four samples, 31%)
and Eg (three samples, 23%). Types Ec, Em, Gg,
Ib and Jf were detected in one sample (8%) each.
A mixed infection with types Bi and Ji was
detected in one of the seven samples from which
ampliﬁcation products were randomly cloned.
Of the three patients with two specimens
collected during the same PcP episode, the mtLSU
rRNA sequence changed in one patient, with the
mixed infection with genotypes 1 and 2 observed
in the ﬁrst specimen changing to a single geno-
type 2 infection in the second specimen. The ITS
type changed from Ei to Eg, from Ei to Hg, and
from Cn to Eg, respectively, while the DHPS gene
always yielded the Wt sequence.
No statistically signiﬁcant associations were
observed between HIV-positive or HIV-negative
patients and the three loci sequences included in
this study. Similarly, there was no signiﬁcant
association among the three loci sequences and
either PcP patients or asymptomatic P. jirovecii
colonisation.
There was an apparently uniform distribution
of mtLSU rRNA, DHPS and ITS sequences in both
groups of isolates. No signiﬁcant association was
found between the DHPS gene and the other two
loci. However, a correlation between mtLSU
rRNA genotype 1 and ITS type Eg (Fig. 1) was
revealed, with ITS type Eg being signiﬁcantly
more frequent among isolates with mtLSU rRNA
genotype 1 (p 0.007). No other statistically signif-
icant associations were observed between ITS
types and mtLSU rRNA genotypes (Fig. 1).
DISCUSSION
Multilocus genotyping enables simultaneous
description of several loci, thereby giving more
information for strain characterisation than geno-
typing at a single locus. The technique can be
used to characterise P. jirovecii isolates and to
investigate the temporal and geographical diver-
sity of P. jirovecii isolates in relation to various
demographical and clinical data concerning
infected patients [19,22,29,30]. To our knowledge,
Table 3. Pneumocystis jirovecii internal transcribed spacer
(ITS) region types detected in samples from Lisbon
(Portugal) and Seville (Spain)
ITS typea
Number (%)
of isolates
Portugal
Eg 16 (29)
Cg 7 (13)
Gg 5 (9)
Cn, Bi 3 (5)
Ai, Ce, Eb, Eh, Ei, Hg 2 (4)
De, Dg, Jf, Ng, Oe, ‘Ho’ 1 (2)
Mixtureb 3 (5)
Spain
Bi 4 (31)
Eg 3 (23)
Ec, Em, Gg, Ib, Jf 1 (8)
Mixtureb 1 (8)
aTwenty-one ITS types are identiﬁed according to Lee et al. [27] and one (‘Ho’)
according to Totet et al. [28].
bSamples containing mixed genotypes.
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Fig. 1. Frequencies (%) of mitochondrial large-subunit
(mtLSU) rRNA genotypes and internal transcribed spacer
(ITS) types in Portuguese and Spanish samples, considered
as a pool. The three largely representative mtLSU rRNA
genotypes and the four most relevant ITS types in the
present study are presented.
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the present study of populations from Lisbon and
Seville, respectively, is the ﬁrst molecular study of
the P. jirovecii mtLSU rRNA locus in the Portu-
guese population and of the P. jirovecii ITS
regions of the nuclear rRNA operon in the
Spanish population.
The allelic frequency distribution analysis
revealed that mtLSU rRNA genotype 1 was the
most prevalent genotype in both populations
(57%), as has been found in previous studies [9].
This genotype showed a higher frequency among
the Spanish samples (64%) than among the
Portuguese samples (49%). Genotype 3 (25%)
was the second most common among the Spanish
samples, and genotype 2 (11%) was the third
most common. These results are in agreement
with data reported for a similar geographical
population [9]. Inversely, in the Portuguese iso-
lates, genotype 2 (22%) was the second most
common and genotype 3 was the third most
common (18%). Other studies from different
geographical regions (e.g., the USA and the UK
[19,21]) have revealed an mtLSU rRNA pattern
identical to that of the Portuguese samples, but
dissimilar from that of the Spanish samples.
Furthermore, the Spanish samples showed a
higher incidence of genotype 1 than that detected
in these previous studies. Epidemiological factors
inherent to Lisbon and Seville, e.g., geographical
and climatic characteristics (Lisbon has an Atlan-
tic temperate climate with moderate humidity,
while Seville is hotter and dryer, with a Mediter-
ranean climate), may inﬂuence the circulation and
transmission of the different P. jiroveccii geno-
types [19,31,32]; it would therefore be interesting
to compare these frequency distribution patterns
with those of other European cities.
With respect to the DHPS gene sequence data,
the Wt sequence was predominant in both pop-
ulations, as reported previously [9,33]. Mutant
genotypes appeared at a low frequency, i.e., 7% in
the Portuguese samples and 22% in the Spanish
samples. Nevertheless, the distribution of DHPS
genotypes in both populations was identical, and
similar to the distributions revealed in several
other recent European studies [32,34]. However,
the Iberian pattern differs from the distribution
observed in Lyon (France), where 16% of muta-
tions correspond to a point mutation at codon 57,
compared with 0% for the Portuguese samples
and 6% for the Spanish samples. The frequent use
in Lyon of prophylactic regimens containing
fansidar, which contrasts with the normal use of
co-trimoxazole in Portugal and Spain, may
account for this difference. Indeed, the use of
fansidar has been associated previously with the
occurrence of mutations at codon 57 [33]. In
contrast to studies in North America [12,14,15,19],
Iberian samples showed a higher prevalence of
the Wt sequence and a lower frequency of
mutations, which conﬁrms previous ﬁndings that
the prevalence of P. jirovecii DHPS gene muta-
tions is usually lower in Europe than in the
USA [14,32]. These data suggest that there could
be geographical variation in the prevalence of
P. jirovecii DHPS gene mutations, possibly caused
by intrinsic epidemiological factors that inﬂuence
the circulation and transmission of different
genotypes, or perhaps because of differing
use of sulphonamides for PcP prophylaxis
[12,19,31,32,35]. A decline in the DHPS gene
mutation frequency has already been described
in the Portuguese population and in other Euro-
pean populations [13,36], and this may be related
to the decreased use of prophylaxis with sulph-
onamides following the introduction of HAART
[5]. DHPS mutations could help the parasite to
resist the effects of the drug, but could be
disadvantageous in the absence of the drug, as
observed for other parasites [37,38]. Nevertheless,
DHPS gene mutations selected by the use of
sulphonamides might occur naturally and be
transmitted, albeit at low frequencies. Indeed,
the presence of P. jirovecii mutant genotypes in
individuals who have not been exposed to sul-
phonamides, or in individuals colonised with
P. jirovecii, could have important implications
for the transmission and epidemiology of this
infection [6,14,33,35]. Trimethoprim–sulphameth-
oxazole is an effective drug combination when
used against P. jirovecii infections; however, the
need for the development of new agents for
alternative prophylaxis and therapy of PcP
should be considered [12,14,15].
With respect to ITS types, the present results
revealed a signiﬁcant diversity in both popula-
tions because of the high sequence variability in
these genomic regions [17,25,27]. The data suggest
a probable dominance of ITS type Eg in the
Portuguese population, as reported previously
[17], but the second most common ITS type in the
Portuguese population was Cg, followed by Gg,
which is in contrast to previous ﬁndings [17].
In the Spanish population, it was difﬁcult to
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determine the prevalence of the ITS types because
of the low ampliﬁcation rate observed for these
regions. However, an apparent prevalence of
types Bi and Eg was detected. Nevertheless, type
E was the dominant ITS1 sequence in both
populations. Considering both groups of samples
as a pool, the results obtained in this work are
consistent with previous studies [24,27,28,34] in
which Eg was repeatedly found to be the most
prevalent ITS type. Bi was the most common ITS
type among Spanish samples, but additional
studies involving larger numbers of samples are
required to properly determine the P. jirovecii ITS
type distribution in this population.
The presence of multiple ITS types in the same
specimens suggests that genetically different
microorganisms could be present; hence,
P. jirovecii infection is not necessarily clonal
[25,28]. Co-infection is an important issue to take
into consideration for PcP transmission dynamics.
Also, in the three patients from whom two
specimens were collected during the same PcP
episode, the ITS type changed from Ei to Eg, from
Ei to Hg, and from Cn to Eg, respectively. This
could be caused by mixed infections combined
with inadequate sampling, or by an inability to
detect the presence of organisms that constituted
a minor fraction of the total organisms in the
sample [17].
In a previous study, Meshnick et al. [39]
reported that DHPS mutations are common in
types Eb, Ee and Eg, and even more frequent in
type Ne. In contrast, ITS type Eg samples from
the present study showed a lower frequency of
polymorphism for the DHPS gene (11% of
DHPS mutants in ITS type Eg, compared
with 60% observed by Meshnick et al. [39]).
Spanish samples had a modest ampliﬁcation
rate for DHPS sequences and, especially, ITS
sequences, mostly associated with samples from
HIV-negative patients with pulmonary disorders
who were colonised by P. jirovecii. This may be
a consequence of a low parasite load and ⁄ or the
fact that these two genes occur only as single-
copy sequences in the P. jirovecii genome
[9,13,25,29].
The statistical association observed between
mtLSU rRNA genotype 1 and ITS type Eg
(p 0.007) is probably related to the high preva-
lence of these sequences in the populations
studied. However, further studies with a larger
number of samples should be conducted in order
to clarify this relationship. Considering both
groups of samples as a pool, if mtLSU rRNA
genotype 1 is detected in Lisbon or Seville, there
is a 41% probability that this microorganism has
ITS type Eg (p 0.007).
In conclusion, multilocus genotyping analysis
of the mtLSU rRNA gene, the DHPS gene and the
ITS of the nuclear rRNA operon provided more
useful epidemiological information than studies
at only one or two genetic loci [17,25,30,40]. The
present study provided useful information for
understanding P. jirovecii infection patterns,
causes and control in Portugal and Spain. Further
studies are required to investigate the relationship
between P. jirovecii haplotypes and drug resis-
tance, virulence and transmission.
ACKNOWLEDGEMENTS
We thank C. Cunha (Unit of Molecular Biology, Institute of
Hygiene and Tropical Medicine, Lisbon, Portugal) for helpful
assistance with cloning. The authors declare that they have no
conﬂicting or dual interests in respect of this work.
REFERENCES
1. Redhead SA, Cushion MT, Frenkel JK, Stringer JR. Pneu-
mocystis and Trypanosoma cruzi: nomenclature and typiﬁ-
cations. J Eukaryot Microbiol 2006; 53: 2–11.
2. Sringer JR, Beard CB, Miller RF, Wakeﬁeld AE. A new
name (Pneumocystis jirovecii) for Pneumocystis from hu-
mans. Emerg Infect Dis 2002; 8: 891–896.
3. Wakeﬁeld AE. Pneumocystis carinii. Br Med Bull 2002; 61:
175–188.
4. Barry SM, Johnson MA. Pneumocystis carinii pneumonia: a
review of current issues in diagnosis and management.
HIV Med 2001; 2: 123–132.
5. Morris A, Lundgren JD, Masur H et al. Current epidemi-
ology of Pneumocystis pneumonia. Emerg Infect Dis 2004;
10: 1713–1720.
6. Matos O, Costa MC, Correia I et al. Pneumocystis jirovecii
carriage in Portuguese immunocompetent patients: pre-
liminary results. J Eukaryot Microbiol 2003; 50 (suppl 1):
647–648.
7. Matos O, Costa MC, Correia I et al. Pneumocystis jiroveci
infection in immunocompetent patients with pulmonary
disorders, in Portugal. Acta Med Port 2006; 19: 121–126.
8. Medrano FJ, Montes-Cano M, Conde M et al. Pneumocystis
jirovecii in general population. Emerg Infect Dis 2005; 11:
245–250.
9. Montes-Cano MA, de la Horra C, Martı´n-Juan J et al.
Pneumocystis jiroveci genotypes in the Spanish population.
Clin Infect Dis 2004; 39: 123–128.
10. Vidal S, de la Horra C, Martı´n J et al. Pneumocystis jirovecii
colonisation in patients with interstitial lung disease. Clin
Microbiol Infect 2006; 12: 231–235.
11. Pifer LL, Hughes WT, Stagno S, Woods D. Pneumocystis
carinii infection: evidence for high prevalence in normal
Esteves et al. P. jirovecii genotyping proﬁles 361
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 356–362
and immunosuppressed children. Pediatrics 1978; 61:
35–41.
12. Armstrong W, Meshnick S, Kanzanjian P. Pneumocystis
carinii mutations associated with sulfa and sulfone
prophylaxis failures in immunocompromised patients.
Microb Infect 2000; 2: 61–67.
13. Costa MC, Gaspar J, Mansinho K, Esteves F, Antunes F,
Matos O. Detection of Pneumocystis jirovecii dihydro-
pteroate synthase polymorphisms in patients with Pneu-
mocystis pneumonia. Scand J Infect Dis 2005; 37: 766–771.
14. Kanzanjian P, Armstrong W, Hossler PA et al. Pneumo-
cystis carinii mutations are associated with duration of
sulfa or sulfone prophylaxis exposure in AIDS patients. J
Infect Dis 2000; 182: 551–557.
15. Ma L, Borio L, Masur H, Kovacs JA. Pneumocystis carinii
dihydropteroate synthase but not dihydrofolate reductase
gene mutations correlate with prior trimethoprim–sulfa-
methoxazole or dapsone use. J Infect Dis 1999; 180: 1969–
1978.
16. Costa MC, Esteves F, Antunes F, Matos O. Genetic char-
acterization of the dihydrofolate reductase gene of Pneu-
mocystis jirovecii isolates from Portugal. J Antimicrob
Chemother 2006; 58: 1246–1249.
17. Matos O, Lee C-H, Jin S et al. Pneumocystis jiroveci in
Portuguese immunocompromised patients: association of
speciﬁc ITS genotypes with treatment failure, bad clini-
cal outcome and childhood. Infect Genet Evol 2003; 3:
281–285.
18. Walker DJ, Wakeﬁeld AE, Dohn MN et al. Sequence
polymorphisms in the Pneumocystis carinii cytochrome b
gene and their association with atovaquone prophylaxis
failure. J Infect Dis 1998; 178: 1767–1775.
19. Beard CB, Carter JL, Keely SP et al. Genetic variation
in Pneumocystis carinii isolates from different geographic
regions: implications for transmission. Emerg Infect Dis
2000; 6: 265–272.
20. Wakeﬁeld AE, Fritscher CC, Malin AS, Gwanzura L,
Hughes WT, Miller RF. Genetic diversity in human-de-
rived Pneumocystis carinii isolates from four geographical
locations shown by analysis of mitochondrial rRNA gene
sequences. J Clin Microbiol 1994; 32: 2959–2961.
21. Miller RF, Lindley AR, Copas A, Ambrose HE, Davies
RJO, Wakeﬁeld AE. Genotypic variation in Pneumocystis
jirovecii isolates in Britain. Thorax 2005; 60: 679–682.
22. Miller RF, Wakeﬁeld AE. Pneumocystis carinii genotypes
and severity of pneumonia. Lancet 1999; 353: 2039–2040.
23. Wakeﬁeld AE, Pixley FJ, Benerji S et al. Ampliﬁcation of
mitochondrial ribosomal RNA sequences from Pneumo-
cystis carinii DNA of rat and human origin. Mol Biochem
Parasitol 1990; 43: 69–76.
24. Atzori C, Valerio A, Fantoni G, Drago L, Gismondo MR,
Gargnel A. Pneumocystis carinii ITS typing: doubtful evi-
dence of genotype-related virulence. J Eukaryot Microbiol
2001; 48 (suppl 1): 147S.
25. Lu JJ, Bartlett MS, Shaw MM et al. Typing of Pneumocystis
carinii strains that infect humans based on nucleotide
sequence variations of internal transcribed spacers of
rRNA genes. J Clin Microbiol 1994; 32: 2904–2912.
26. Tsolaki AG, Beckers P, Wakeﬁeld AE. Pre-AIDS era iso-
lates of Pneumocystis carinii f. sp. hominis: high genotype
similarity with contemporary isolates. J Clin Microbiol
1998; 36: 90–93.
27. Lee CH, Helweg-Larsen J, Tang X et al. Update on Pneu-
mocystis carinii f. sp. hominis typing based on nucleotide
sequence variations in internal transcribed spacer regions
of rRNA genes. J Clin Microbiol 1998; 36: 734–741.
28. Totet A, Pautard JC, Raccurt C, Roux P, Nevez G. Geno-
types at the internal transcribed spacers of the nuclear
rRNA operon of Pneumocystis jiroveci in nonimmunosup-
pressed infants without severe pneumonia. J Clin Microbiol
2003; 41: 1173–1180.
29. Wakeﬁeld AE, Lindley AR, Ambrose HE, Denis CM,
Miller RF. Limited asymptomatic carriage of Pneumocystis
jiroveci in human immunodeﬁciency virus-infected
patients. J Infect Dis 2003; 187: 901–908.
30. Miller RF, Lindley AR, Ambrose HE, Aliouat-Denis CM,
Wakeﬁeld AE. Multilocus genotyping of Pneumocystis
jirovecii from adult HIV-infected patients with Pneumo-
cystis pneumonia. J Eukaryot Microbiol 2003; 50 (suppl):
654–655.
31. Miller RF, Evans HE, Copas AJ, Cassell JA. Climate and
genotypes of Pneumocystis jirovecii. Clin Microbiol Infect
2007; 13: 445–448.
32. Costa MC, Helweg-Larsen J, Lungren B, Antunes F, Matos
O. Mutations in the dihydropteroate synthase gene of
Pneumocystis jiroveci isolates from Portuguese patients
with Pneumocystis pneumonia. Int J Antimicrob Agents 2003;
22: 516–520.
33. Rabodonirina M, Nahimana A, Weber R, Francioli P, Bille
J, Hauser PM. Geographical variation in the prevalence of
Pneumocystis jirovecii dihydropteroate synthase mutations
within Western Europe. J Eukaryot Microbiol 2006; 53
(suppl 1): S112–S113.
34. Valerio A, Tronconi E, Mazza F, Gargnel A, Fantoni G,
Atzori C. DHPS-mutated isolates of Pneumocystis jirovecii
from HIV-infected individuals: analysis of related ITS
genotypes. J Eukaryot Microbiol 2006; 53 (suppl 1): S108–
S109.
35. Kazanjian P, Locke AB, Hossler PA et al. Pneumocystis
carinii mutations associated with sulfa and sulfone pro-
phylaxis failures in AIDS patients. AIDS 1998; 12: 873–
878.
36. Helweg-Larsen J, Benﬁeld TL, Eugen-Olsen J, Lundgren
JD, Lundgren B. Effects of mutations in Pneumocystis carinii
dihydropteroate synthase gene on outcome of AIDS-
associated P. carinii pneumonia. Lancet 1999; 354: 1347–
1351.
37. Hastings IM, Donnelly MJ. The impact of antimalarial
drug resistance mutations on parasite ﬁtness, and its
implications for the evolution of resistance. Drug Resist
Update 2005; 8: 43–50.
38. Walliker D, Hunt P, Babiker H. Fitness of drug-resistant
malaria parasites. Acta Trop 2005; 94: 251–259.
39. Meshnick SR, Hossler PA, Enger KS et al. Distribution of
DHPS mutations among ITS subtypes of P. carinii f. sp.
hominis. J Eukaryot Microbiol 2001; suppl:126S–128S.
40. Hauser PM, Blanc DS, Sudre P et al. Genetic diversity
of Pneumocystis carinii in HIV-positive and -negative
patients as revealed by PCR-SSCP typing. AIDS 2001;
15: 461–466.
362 Clinical Microbiology and Infection, Volume 14 Number 4, April 2008
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 356–362
